CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease

Table 3

Studies of CD80 in minimal change disease that are support or against in both animals and humans.

Animal studies	Stance on CD80	Human studies	Stance on CD80
Reiser et al., 2004 [24]	Support	Garin et al., 2009 [22]	Support
Shi et al., 2011 [149]	Support	Garin et al., 2010 [100]	Support
Ishimoto et al., 2013 [102]	Support	Ishimoto et al., 2013 [101]	Support
Novelli et al., 2016 [20]	Against	Yu et al., 2013 [23]	Support
Rivard et al., 2018 [150]	Support	Cara-Fuentes et al., 2014 [26]	Support
Khullar et al., 2018 [95]	Support	Novelli et al., 2016 [20]	Against
		Mishra et al., 2017 [151]	Support
		Liao et al., 2017 [94]	Support
		Minamikawa et al., 2018 [152]	Against
		Zhao et al., 2018 [153]	Support
		Ling et al., 2018 [8]	Support
		Ahmed et al., 2018 [154]	Support
		Bhatia et al., 2018 [155]	Support
		Isom et al., 2019 [78]	Support
		Cara-Fuentes et al., 2020 [156]	Support
		Chen et al., 2020 [157]	Support
		Gonzalez et al., 2020 [158]	Support